ClinConnect ClinConnect Logo
Search / Trial NCT05862818

Can Food Timing Reduce Your Diabetes Risk?

Launched by BRIGHAM AND WOMEN'S HOSPITAL · May 11, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Glucose Tolerance Diet Induced Thermogenesis Fat Tolerance

ClinConnect Summary

This clinical trial, titled "Can Food Timing Reduce Your Diabetes Risk?", is looking to find out if when we eat our meals can affect our overall health, especially in relation to metabolic conditions like diabetes. The study will involve healthy participants who will spend time in a research facility, where they will eat specific test meals and have their blood drawn regularly to monitor their health.

To participate, individuals should be between the ages of 65 and 74 and have a body mass index (BMI) between 18.5 and 29.9, which means they should not be underweight or obese. Participants should not have any serious medical or mental health issues, and they should not smoke or have any drug or alcohol dependencies. If you join this trial, you can expect to spend some time in a controlled setting, eating provided meals and undergoing health assessments to help researchers understand the impact of meal timing on health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Healthy with no acute or chronic medical and psychiatric disorders
  • BMI: 18.5-29.9 kg/m2
  • Exclusion Criteria:
  • Smokers, current tobacco or e-cigarette use
  • Drug or alcohol dependency
  • Pregnant

About Brigham And Women's Hospital

Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Frank Scheer, PhD

Principal Investigator

Brigham and Women's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported